Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Indian J Psychiatry. 2009 Jan;51(1):12-25. doi: 10.4103/0019-5545.44900.

The prevention and treatment of cognitive decline and dementia: An overview of recent research on experimental treatments.

Author information

  • 1Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore - 560 029, India.

Abstract

The prevention and treatment of cognitive impairment in the elderly has assumed increasing importance in an aging population. This article presents a qualitative review of recent research on experimental interventions for the prevention and treatment of mild cognitive impairment and Alzheimer's disease in elderly subjects. Interventions addressed range from lifestyle measures to pharmacological treatments. Epidemiological studies suggest that dietary measures, physical exercise, and mental activity may reduce the risk of cognitive impairment and Alzheimer's disease in elderly subjects. Statins may protect against incident dementia, and lithium may convey similar benefits to bipolar patients. Ginkgo appears ineffective as a primary preventive measure. Donepezil but not Vitamin E may benefit persons with mild cognitive impairment. Experimental treatments potentially useful for Alzheimer's disease include dimebon, PBT2 and etanercept; the safety and efficacy of the Alzheimer's vaccine remains to be proven, and growth hormone secretagogue and tarenflurbil are likely ineffective. Herbal treatments merit study in elderly subjects with cognitive syndromes.

KEYWORDS:

Alzheimer's disease; Mild cognitive impairment; cognition; dementia; elderly

PMID:
19742190
[PubMed]
PMCID:
PMC2738400
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
    Loading ...
    Write to the Help Desk